Risk factors for post-COVID pulmonary fibrosis :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Evaluation of risk factors linked with risk of post-COVID pulmonary fibrosis

Evaluation of risk factors linked with risk of post-COVID pulmonary fibrosis Evaluation of risk factors linked with risk of post-COVID pulmonary fibrosis
Evaluation of risk factors linked with risk of post-COVID pulmonary fibrosis Evaluation of risk factors linked with risk of post-COVID pulmonary fibrosis

A single-center observational study explored prevalence and risk factors linked with PCF and other complications in people discharged following SARS-CoV-2 infection.

See All

Key take away

People who had serious coronavirus infection, specifically those who were on invasive ventilation and those who experience persistent breathlessness are more vulnerable to develop post-covid pulmonary fibrosis (PCF). They should undergo high-resolution chest computed tomography and respiratory follow-up.  

Background

A single-center observational study explored prevalence and risk factors linked with PCF and other complications in people discharged following SARS-CoV-2 infection.

Method

With the aid of a set protocol, the recruited participants had phone assessments six weeks after hospital discharge following coronavirus infection. People suffering from major respiratory symptoms were examined with the aid of computed tomography pulmonary angiogram, pulmonary function tests, and echocardiogram. The prevalence of fatigue, myalgia, PCF, and psychological symptoms and the risk factors associated with these were evaluated.

Result

A significant proportion of people were reported to have psychological symptoms (19.5%), persistent fatigue (45.1%), myalgia (20.5%), and breathlessness (36.5%). In 9.5% of people, PCF was observed and was linked with persistent breathlessness at six weeks [adjusted odds ratio (OR) 5.02] and inpatient ventilation (OR 4.45).

It was found to be more common in males and in individuals having peak C-Reactive Protein >171.5 mg/L, peak white blood cell count ≥12 × 109/L, severe inpatient SARS-CoV-2 chest X-ray alterations and computed tomography alterations. For persisting fatigue and myalgia, ventilation was also noted to be an important risk factor. Myalgia was also highly prevalent in people having intense cytokine storm and serious SARS-CoV-2 inpatient chest X-ray alterations.

Conclusion

Survivors of severe coronavirus infection are at risk of PCF and long term multi-system complications. Therefore, people discharged after coronavirus infection must be examined utilizing a set protocol by a multidisciplinary team. 

Source:

Respiratory Medicine

Article:

Complications after discharge with COVID-19 infection and risk factors associated with development of post-COVID pulmonary fibrosis

Authors:

Dr Raminder Aul et al.

Comments (1)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: